Skip to main content
. 2021 Jun 16;13(12):3017. doi: 10.3390/cancers13123017

Table 2.

Characteristics of the study population by KIF14 immunoexpression groups.

Variables n (%) KIF14 IS p -Value KIF14 PS p-Value KIF14 IRS p-Value
n = 21 (30.88) n = 47 (69.12) n = 31
(45.59)
n = 37 (54.41) n = 30 (44.12) n = 38 (55.88)
Age (years)
≤ 60 29 (42.65) 8 (27.59) 21 (72.41) 0.79 14 (48.28) 15 (51.72) 0.81 14 (48.28) 15 (51.72) 0.63
> 60 39 (57.35) 13 (33.33) 26 (66.67) 17 (43.59) 22 (56.41) 16 (41.03) 23 (58.97)
Gender
Male 34 (50.00) 8 (23.53) 26 (76.47) 0.29 15 (44.12) 19 (55.88) >0.99 13 (38.24) 21 (61.76) 0.46
Female 34 (50.00) 13 (38.24) 21 (61.76) 16 (47.06) 18 (52.94) 17 (50.00) 17 (50.00)
Grading
G1 5 (7.35) 1 (20.00) 4 (80.00) 0.10 3 (60.00) 2 (40.00) 0.40 2 (40.00) 3 (60.00) 0.15
G2 55 (80.88) 20 (36.36) 35 (63.64) 26 (47.27) 29 (52.73) 27 (49.09) 28 (50.91)
G3 8 (11.77) 0 (0.00) 8 (100.0) 2 (25.00) 6 (75.00) 1 (12.50) 7 (87.50)
pT status
T1 10 (15.87) 4 (40.00) 6 (60.00) 0.56 6 (60.00) 4 (40.00) 0.40 5 (50.00) 5 (50.00) 0.83
T2 43 (68.25) 11 (25.58) 32 (74.42) 19 (44.19) 24 (55.81) 17 (39.54) 26 (60.47)
T3-T4 10 (15.87) 2 (20.00) 8 (80.00) 3 (30.00) 7 (70.00) 4 (40.00) 6 (60.00)
pN status
N0 30 (45.46) 8 (26.67) 22 (73.33) 0.44 18 (60.00) 12 (40.00) 0.08 13 (43.33) 17 (56.67) 0.81
N1-N2 36 (54.54) 13 (36.11) 23 (63.89) 13 (36.11) 23 (63.89) 17 (47.22) 19 (52.78)
TNM stage
I 24 (38.71) 6 (25.00) 18 (75.00) 0.43 15 (62.50) 9 (37.50) 0.12 10 (41.67) 14 (58.33) 0.86
II 24 (38.71) 6 (25.00) 18 (75.00) 8 (33.33) 16 (66.67) 10 (41.67) 14 (58.33)
III-IV 14 (22.58) 6 (42.86) 8 (57.14) 6 (42.86) 8 (57.14) 7 (50.00) 7 (50.00)
Location
Head 60 (88.24) 19 (31.67) 41 (68.33) >0.99 28 (46.67) 32 (53.33) 0.72 26 (43.33) 34 (56.67) 0.72
Body-tail 8 (11.76) 2 (25.00) 6 (75.00) 3 (37.50) 5 (62.50) 4 (50.00) 4 (50.00)
VI
Absent 39 (72.22) 14 (35.90) 25 (64.10) 0.18 20 (51.28) 19 (48.72) >0.99 19 (48.72) 20 (51.28) 0.37
Present 15 (27.78) 2 (13.33) 13 (86.67) 7 (46.67) 8 (53.33) 5 (33.33) 10 (66.67)
PNI
Absent
Present

22 (34.38)

5 (22.73)

17 (77.27)

0.57

10 (45.45)

12 (54.55)

>0.99
9 (40.91) 13 (59.09)
>0.99
42 (65.62) 14 (33.33) 28 (66.67) 19 (45.24) 23 (54.76) 18 (42.86) 24 (57.14)

Abbreviations: IS—immunointensity; PS—immunopercentage; IRS—immunoreactive score; VI—vascular invasion; PNI—perineural invasion. Chi-square or Fisher’s exact test.